ライブ
Lonza NewsSmall-Molecule CDMO Outlook: What Lies Ahead - DCAT Value Chain InsightsClinical OMICsPioneering Innovation in Transplant DiagnosticsFierceBiotechRoche nabs EU approval on label expansions for companion dx platformFierceBiotechGenentech executes another round of layoffs, with 3 VPs axedScienceLaser-boosted microscopes could reveal new drug targets, sharpen views inside cellsScienceThe ocean current that warms Europe may be more resilient than fearedClinical OMICsCyclana Bio Is Exploring the Extracellular Matrix to Treat EndometriosisFierceBiotechAI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data findsRoche MediaGenentech executes another round of layoffs, with 3 VPs axed - Fierce BiotechClinical OMICsHigher Vitamin C Levels in Blood Linked to Healthier Aging BrainsClinical OMICsStopping Neurodegeneration in Place with VaccinesClinical OMICsRemote Monitoring Benefits Unclear After Hospitalization for Serious Infection
Harvard Bioscience 2026年3月12日

Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - Yahoo Finance

Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - Yahoo Finance

原文
本文は利用できません。元の情報源をご確認ください。